Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications

Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Aug 5, 2021

Keywords

ClinConnect Summary

This clinical trial is exploring the use of a special imaging technique called F-choline PET to help doctors better understand certain medical conditions, especially cancers. F-choline is a substance that some cancers may absorb more than normal cells, and researchers believe it could provide valuable information about tumors in the body. The trial aims to find new ways to use F-choline PET imaging for conditions like parathyroid adenomas, cervical cancers, and liver cancers. The researchers will also assess how safe this imaging method is and whether it can change how patients are managed or treated based on the results.

To participate, individuals aged 65 and older with known or suspected conditions that might benefit from F-choline PET imaging can enroll in the study. Participants may undergo up to four imaging exams per year, as needed, to help monitor their health or response to treatment. It’s important to note that pregnant women, breastfeeding mothers, and children under 18 are not eligible for this trial. By taking part, patients may receive new insights into their condition that could lead to changes in their treatment plan.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any patient with a known or suspected condition in which F-choline PET imaging might provide clinically useful information.
• Exclusion Criteria:
• • Pregnancy
• • Breastfeeding woman, unwilling to discontinue breastfeeding for 48 hours
• • Known allergy to F-choline or any excipients
• • Pediatric patient (\< 18 years old)